We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk
Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk
Status: Archived
Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk
Updated: 1/1/1970
Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk
Status: Archived
Updated: 1/1/1970
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
Updated: 1/1/1970
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
Updated: 1/1/1970
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
Updated: 1/1/1970
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
Updated: 1/1/1970
An 8 Week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination With Valsartan Versus Valsartan Alone in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Vascular Inflammation in Adolescents With Type 1 Diabetes
Prevalence of Oxidative Stress, Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness (cIMT) and Biomarkers of Vascular Inflammation in Adolescents With Type-1 Diabetes Mellitus (T1DM)
Status: Archived
Vascular Inflammation in Adolescents With Type 1 Diabetes
Updated: 1/1/1970
Prevalence of Oxidative Stress, Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness (cIMT) and Biomarkers of Vascular Inflammation in Adolescents With Type-1 Diabetes Mellitus (T1DM)
Status: Archived
Updated: 1/1/1970
Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes
Effect of Nurse-Based, Protocol-Driven, Case-Management Utilizing Home Telemonitoring and Home HbA1c Measurement on Diabetes and Blood Pressure Outcomes
Status: Archived
Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes
Updated: 1/1/1970
Effect of Nurse-Based, Protocol-Driven, Case-Management Utilizing Home Telemonitoring and Home HbA1c Measurement on Diabetes and Blood Pressure Outcomes
Status: Archived
Updated: 1/1/1970
Macular Edema Incidence/Severity Reduction With Nevanac
Status: Archived
Macular Edema Incidence/Severity Reduction With Nevanac
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Controlling Blood Sugar Levels in Preventing Infection in Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Effects of Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
Status: Archived
Controlling Blood Sugar Levels in Preventing Infection in Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Updated: 1/1/1970
Effects of Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
Status: Archived
Updated: 1/1/1970
Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
Status: Archived
Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
Updated: 1/1/1970
Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
Status: Archived
Updated: 1/1/1970
Study to Evaluate Safety and Pharmacokinetics of ARRY-403 in Patients With Type 2 Diabetes
A Randomized, Double-Blind (Sponsor Excepted), Placebo-Controlled Multiple Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Orally Administered ARRY-403 in Patients With Type 2 Diabetes
Status: Archived
Study to Evaluate Safety and Pharmacokinetics of ARRY-403 in Patients With Type 2 Diabetes
Updated: 1/1/1970
A Randomized, Double-Blind (Sponsor Excepted), Placebo-Controlled Multiple Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Orally Administered ARRY-403 in Patients With Type 2 Diabetes
Status: Archived
Updated: 1/1/1970
Study to Evaluate Safety and Pharmacokinetics of ARRY-403 in Patients With Type 2 Diabetes
A Randomized, Double-Blind (Sponsor Excepted), Placebo-Controlled Multiple Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Orally Administered ARRY-403 in Patients With Type 2 Diabetes
Status: Archived
Study to Evaluate Safety and Pharmacokinetics of ARRY-403 in Patients With Type 2 Diabetes
Updated: 1/1/1970
A Randomized, Double-Blind (Sponsor Excepted), Placebo-Controlled Multiple Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Orally Administered ARRY-403 in Patients With Type 2 Diabetes
Status: Archived
Updated: 1/1/1970
Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
Status: Archived
Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
Updated: 1/1/1970
Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
Status: Archived
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Updated: 1/1/1970
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Status: Archived
Updated: 1/1/1970
SeaCare's Care Coordination for Diabetes Management in a Primary Care Office
Improved Management of Type II Diabetes in a Primary Care Office With Targeted Case Management
Status: Archived
SeaCare's Care Coordination for Diabetes Management in a Primary Care Office
Updated: 1/1/1970
Improved Management of Type II Diabetes in a Primary Care Office With Targeted Case Management
Status: Archived
Updated: 1/1/1970